Atypical Cerebellar Involvement in MOG Antibody-Associated Disease (MOGAD) in Early Childhood
DOI:
https://doi.org/10.46531/sinapse/IN/230001/2023Keywords:
Autoantibodies, Child, Encephalomyelitis, Acute Disseminated/diagnostic imaging, Encephalomyelitis, Acute Disseminated/drug therapy, Myelin-Oligodendrocyte GlycoproteinDownloads
References
Zhang M, Shen J, Zhou S, Du X, Li W, Yu L, et al. Clinical and neuroimaging characteristics of pediatric acute disseminating encephalomyelitis with and without antibodies to myelin oligodendrocyte glycoprotein. Front Neurol. 2020;11:593287. doi:10.3389/fneur.2020.593287.
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immunemediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19:12617. doi: 10.1177/1352458513484547.
Armindo RD, Healion E, Palavra F. The spectrum of antiMOG associated demyelinating diseases in children: a review illustrated with clinical cases. Sinapse. 2020;20:17-24. doi: 10.46531/sinapse/AR/200002/2020.
Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86:265-72. doi: 10.1136/jnnp-2014-308346.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.